Myelodysplastic syndromes are cancers that stem from the development of abnormal blood cells. Symptoms vary widely between patients, ranging from non-existent to debilitating. There are many myelodysplastic syndromes, each with different treatment requirements. Serving patients across New Jersey, Connecticut, Maryland, and the Washington, D.C. area, Regional Cancer Care Associates provides comprehensive, cutting-edge treatment of the full range of myelodysplastic syndromes.
Symptoms of myelodysplastic syndromes vary widely between patients. In the early stages of the disease, some patients do not have any symptoms. However, symptoms can appear and worsen as myelodysplastic syndrome progresses. Common signs include:
There are many types of myelodysplastic syndromes. To identify which one may be present, physicians typically examine the shape and makeup of blood cells under a microscope. Types of myelodysplastic syndromes include:
Evaluation of patients with symptoms that may indicate a myelodysplastic disorder begins with a thorough history and comprehensive medical examination. Physicians also will order a complete blood count (CBC) test. In some cases, physicians may also order a bone marrow biopsy or other tests as part of the diagnostic process.
Physicians typically work to control and manage symptoms, as well as to slow the progression of the disease. If a patient is not experiencing symptoms, doctors may delay treatment and observe the patient’s condition through regular check-ups and testing. However, if symptoms worsen, doctors may recommend the following:
With more than 20 locations in NJ, CT, MD, and the Washington D.C. area, Regional Cancer Care Associates offers comprehensive, compassionate, and convenient care for people with myelodysplastic syndrome. To learn more about treatment, contact us or request an appointment today.
If you need near-term or ongoing care for anemia or another benign blood disorder, schedule an appointment at Regional Cancer Care Associates. Patients have access to a full range of services acrossNew Jersey, Connecticut, Maryland, and the Washington, DC area, making it easy to find a location convenient for you. Contact us today to learn more about our benign hematology services.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.